A related issue showing the importance of clinico-pathological correlation is the occurrence of JAK2 mutations in individuals without clinical or laboratory evidence of an MPN, which in this setting is considered a CHIP mutation [157]. The gene discussed is JAK2; the disease is myeloproliferative disorder.